E-Therapeutics PLC
LSE:ETX
E-Therapeutics PLC
Cash from Investing Activities
E-Therapeutics PLC
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
E-Therapeutics PLC
LSE:ETX
|
Cash from Investing Activities
£15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
21%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Investing Activities
-$127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Investing Activities
-$11m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Investing Activities
-$2.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Investing Activities
-£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cash from Investing Activities
-£21.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
See Also
What is E-Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
15.3m
GBP
Based on the financial report for Jan 31, 2023, E-Therapeutics PLC's Cash from Investing Activities amounts to 15.3m GBP.
What is E-Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
21%